COVID Treatments

The Illinois Department of Public Health has begun distributing a new COVID-19 treatment designed for use in adults with mild-to-moderate cases that are at-risk of severe illness.

This week, the Food and Drug Administration revoked Emergency Use Authorization for COVID-19 antibody drugs from Regeneron and Eli Lilly, a regulatory move that was expected because both drug makers have found that the infusion drugs are less able to target omicron due to the strain’s mutations.

As the omicron variant completes its sweep across the U.S., states with scarce supplies of monoclonal antibody therapies continue to use two treatments that federal health officials warn no longer work against the highly contagious version of the virus that causes COVID-19.

Following the death of a Chicago COVID patient at the center of a debate surrounding the use of the drug ivermectin, NBC 5 is looking into treatment methods currently being used in local hospitals.

Following the death of a Chicago COVID patient at the center of a debate surrounding the use of the drug ivermectin, NBC 5 is looking into treatment methods currently being used in local hospitals. Kate Chappell has the story.